New Mexico · Nonprofit
New Mexico Biotechnology & Biomedical Association Inc
New Mexico Biotechnology & Biomedical Association Inc (New Mexico) receives grants from 1 organization whose IRS filings report $86,000 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($86,000). 1 of them have funded it in more than one year.
- Revenue FY2025
- $114k
- Funders on record
- 1
- Grants received
- $86k
- Net assets
- $26k
What New Mexico Biotechnology & Biomedical Association Inc does
Mission
The New Mexico Biotechnology Biomedical Association, Inc. is a voice of the biotechnology and biomedical industry to state, federal and local governments. It is also a forum for information exchange, developing initiatives to enhance business success and bioscience education.
As stated on its FY2025 Form 990-EZ.
Program
The New Mexico Biotechnology Biomedical Association, Inc. is a voice of the biotechnology and biomedical industry to state, federal and local governments. It is also a forum for information exchange, developing initiatives to en
The program described on its FY2025 Form 990-EZ.
The organization over time
Each line starts at 100 in 2021, so what you read is the shape rather than the size: 150 means half as much again as 2021, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $108k to $41k (−62%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
0% of New Mexico Biotechnology & Biomedical Association Inc’s revenue is contributions — more earned-revenue than three-quarters of its peers (62% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 5 reported years ran a deficit.
Leadership and staff
Chief executive
Greg Byrnes
Executive Director
As listed on its FY2025 Form 990-EZ.
Who funds it, year by year
2021 → 2022: the base held at 1 funder, grant income fell $66k → $14k.
From the IRS filings of New Mexico Biotechnology & Biomedical Association Inc’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
New Mexico Biotechnology & Biomedical Association Inc draws 100% of its grant income from funders outside New Mexico, across 1 state in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
New Mexico Biotechnology & Biomedical Association Inc's revenue fell 33% between 2021 and 2025.
this organization peer median middle 50% of peers· 7,175 community improvement nonprofits $100k–$1M, FY2025
Organizations like New Mexico Biotechnology & Biomedical Association Inc
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New Mexico
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Screen this organization
A dated, signed PDF of the compliance screen for New Mexico Biotechnology & Biomedical Association Inc: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds New Mexico Biotechnology & Biomedical Association Inc?
- New Mexico Biotechnology & Biomedical Association Inc (New Mexico) receives grants from 1 organization whose IRS filings report $86,000 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($86,000). 1 of them have funded it in more than one year.
- How many funders does New Mexico Biotechnology & Biomedical Association Inc have?
- IRS filings report 1 organization giving $86,000 in grants to New Mexico Biotechnology & Biomedical Association Inc, 1 of which have funded it in more than one year.
- Who is the largest funder of New Mexico Biotechnology & Biomedical Association Inc?
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is the largest funder on record, with $86,000 in grants. The full list of funders is on this page.
- How can an organization like New Mexico Biotechnology & Biomedical Association Inc find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New Mexico. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds New Mexico Biotechnology & Biomedical Association →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2021–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing